PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1991 April; 84(4): 206–209.
PMCID: PMC1293183

An audit of surgical treatment of ovarian cancer in a metropolitan health region. Association of Obstetricians and Gynaecologists of the North East Thames Region.

Abstract

The varied application of surgery to the initial treatment of 908 cases of primary ovarian cancer is analysed. In patients with advanced disease (FIGO Stages IIb, III and IV) 256 (46%) of 555 women achieved minimal residual disease status by primary surgery and this proportion fell to 24% when only stages III and IV were considered; of these cases 7% underwent adjunctive intestinal resection or urinary tract surgery. Although not in a clinical trial situation the women achieving minimal residual disease status before chemotherapy survived better in the short term, although long-term survival remained disappointing. In early disease 3% of young women have been subjected to hysterectomy and removal of both ovaries. By contrast, in 16% of women over the age of 40 years with early ovarian cancer bilateral oophorectomy was not carried out.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (809K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol. 1983 Apr;61(4):413–420. [PubMed]
  • Webb MJ. Cytoreduction in ovarian cancer: achievability and results. Baillieres Clin Obstet Gynaecol. 1989 Mar;3(1):83–94. [PubMed]
  • Hudson CN. A radical operation for fixed ovarian tumours. J Obstet Gynaecol Br Commonw. 1968 Nov;75(11):1155–1160. [PubMed]
  • Berek JS, Hacker NF, Lagasse LD. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol. 1984 Nov;64(5):715–720. [PubMed]
  • Heintz AP, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol. 1986 Jun;67(6):783–788. [PubMed]
  • Hudson CN. Victor Bonney Lecture, 1980. Ovarian cancer--a gynaecological disorder? Ann R Coll Surg Engl. 1981 Mar;63(2):118–125. [PMC free article] [PubMed]
  • Piver MS, Barlow JJ, Lele SB. Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol. 1978 Jul;52(1):100–104. [PubMed]
  • Webb MJ, Weaver EW. Intestinal surgery in gynaecological oncology. Aust N Z J Obstet Gynaecol. 1987 Nov;27(4):299–303. [PubMed]
  • Moore GE. Debunking debulking. Surg Gynecol Obstet. 1980 Mar;150(3):395–396. [PubMed]
  • Hammond RH, Houghton CR. The role of bowel surgery in the primary treatment of epithelial ovarian cancer. Aust N Z J Obstet Gynaecol. 1990 May;30(2):166–169. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press